UrgoClean^®

INDICATIONS

• Desloughing phase of chronic exuding wounds (eg leg ulcers, pressure injuries, diabetic foot ulcers)
• Potentially sloughy wounds
  • acute wounds (burns, skin abrasions, traumatic wounds)
  • post-operative wound
  • cancerous wounds

CONTRAINDICATIONS

• Do not use if there is a known sensitivity to UrgoClean^®
• Do not use UrgoClean^® as a surgical sponge for heavily bleeding wounds

PRECAUTIONS

• The soft-adherent TLC layer of UrgoClean^® adheres to latex gloves. It is therefore recommended that the dressing be handled carefully, avoiding any contact with the soft-adherent side or using sterile forceps
• The concomitant use of a cream, lotion, ointment or emulsion is not recommended
• Due to the non-occlusive nature of this dressing, UrgoClean^® can be used on infected wounds under close medical supervision
• During the desloughing process, the wound may appear to be larger in size. This is due to the effective removal of slough
• UrgoClean^® must not be used in a hyperbaric chamber
• Do not re-sterilise the dressing
• Check that the sterile protector is intact before use. Do not use if package is damaged
• Single use sterile individual packaging: re-using a single use dressing may lead to risks of infection

DIRECTIONS FOR USE

PRODUCT OPTIONS

Supplied in boxes of 10 individually packed sterile dressings.

Disclaimer: The product codes published on this website are local reference codes used for ordering, tender, and administrative purposes. They are not the manufacturer's product codes and may differ from the product codes shown on the product label or packaging. The product specifications and intended use remain unchanged.

CLINICAL EVIDENCE

1. Grothier L. Improving clinical outcomes and patient experience through the use of desloughing. Br J Comm Nurs 2015;20(9):1-6.
2. Meaume S et al. The importance of pain reduction through dressing selection in routine wound management the MAPP study. J Wound Care
   2004;13(10): 409-13.